Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05215405
Title Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients With Relapsed or Refractory ALL or LL
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Kathleen Ludwig
Indications

acute lymphoblastic leukemia

Therapies

Navitoclax + Venetoclax

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.